Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK39297 in complement inhibitor-naive PNH
NCT06799546Phase 3Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciprocopan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Feb 2025; status: completed.
02
Drugs
ciprocopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT06799546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06799546.